EUVIMEDEUVIMED entdecken
Open Access

Long-term immunoprophylaxis by TLR9 ligand mediates macrophage-ILC cross-talk against respiratory viral infection

Asuka Joy Tobuse iD, Kouji Kobiyama iD, Jun Tsuchida, Masamitsu N Asaka, Daichi Utsumi iD, Mariana Silva Almeida iD, Yaeko Nakajima-Takagi iD, Motohiko Oshima iD, Tomoya Hayashi iD, Burcu Temizoz iD, Etsushi Kuroda iD, Cevayir Coban iD und 3 weitere

Science Advances · 2026

DOI: 10.1126/sciadv.aeh6480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Asuka Joy Tobuse und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Toll-Like Receptor 9, Macrophages, Respiratory Tract Infections. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapid development of host immunity is critical during the emergence of viral outbreaks when vaccines are not yet available. Here, we demonstrate that CpG oligodeoxynucleotide-schizophyllan complex (K3-SPG) induces antigen-independent, long-term protection against lethal respiratory virus infection. A single intranasal administration successfully enhanced host resistance to infection for as long as 100 days posttreatment. Mechanistically, we observed a lung-restricted biphasic innate activation of macrophages and innate lymphoid cells. Early protection was mediated by CD11b + CD11c + macrophages (DP MΦ) and monocyte-derived interstitial macrophages (IMΦ). Late protection was mediated by innate lymphoid cells that were epigenetically reprogrammed, suggesting that two distinct innate immune subsets contribute to the maintenance of disease tolerance in the lung microenvironment. Deficiency of TLR9 or TNF-α abrogated innate activation and protective immunity. Collectively, these findings demonstrate that adjuvant-induced prophylaxis is a promising approach to enhancing host resistance against respiratory virus infection, involving the biphasic cooperation between innate immune cells in the local tissue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 9MacrophagesRespiratory Tract InfectionsAnimalsOligodeoxyribonucleotidesMiceImmunity, InnateToll-Like Receptor AgonistsLigandsTumor Necrosis Factor-alphaLung

Substanzen

Toll-Like Receptor 9OligodeoxyribonucleotidesToll-Like Receptor AgonistsTlr9 protein, mouseCPG-oligonucleotideLigandsTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Department of Computational Biology and Medical Science, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
  • International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Division of Rheumatology, Department of Medicine, University of California San Diego, La Jolla, CA, USA.
  • Laboratory of Immunoregulation and Vaccine Research, Tsukuba Primate Research Center, National Institutes of Biomedical Innovation, Health and Nutrition, Tsukuba, Japan.
  • Leprosy Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.

ORCID-Profile: Asuka Joy Tobuse, Kouji Kobiyama, Daichi Utsumi, Mariana Silva Almeida, Yaeko Nakajima-Takagi, Motohiko Oshima, Tomoya Hayashi, Burcu Temizoz, Etsushi Kuroda, Cevayir Coban, Yasuhiro Yasutomi, Atsushi Iwama, Ken J Ishii

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Tobuse, A. J., Kobiyama, K., Tsuchida, J., Asaka, M. N., Utsumi, D., Almeida, M. S., Nakajima-Takagi, Y., Oshima, M., Hayashi, T., Temizoz, B., Kuroda, E., Coban, C., Yasutomi, Y., Iwama, A., & Ishii, K. J. (2026). Long-term immunoprophylaxis by TLR9 ligand mediates macrophage-ILC cross-talk against respiratory viral infection. Science Advances. https://doi.org/10.1126/sciadv.aeh6480

Vancouver

Tobuse AJ, Kobiyama K, Tsuchida J, Asaka MN, Utsumi D, Almeida MS, et al. Long-term immunoprophylaxis by TLR9 ligand mediates macrophage-ILC cross-talk against respiratory viral infection. Science Advances. 2026. doi:10.1126/sciadv.aeh6480

BibTeX
@article{Tobuse2026,
  author = {Tobuse, Asuka Joy and Kobiyama, Kouji and Tsuchida, Jun and Asaka, Masamitsu N and Utsumi, Daichi and Almeida, Mariana Silva and Nakajima-Takagi, Yaeko and Oshima, Motohiko and Hayashi, Tomoya and Temizoz, Burcu and Kuroda, Etsushi and Coban, Cevayir and Yasutomi, Yasuhiro and Iwama, Atsushi and Ishii, Ken J},
  title = {Long-term immunoprophylaxis by TLR9 ligand mediates macrophage-ILC cross-talk against respiratory viral infection},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aeh6480}
}
Kostenlos starten →